INTRODUCTION
The evolutionarily conserved CUL4 E3 ligase family, in concert with its DDB1 adaptor, regulates a diverse set of cellular processes including development, transcription, replication and DNA repair (Jackson and Xiong, 2009) . Specificity is conferred by a set of more than 50 WD40 containing substrate receptors, also referred to as DCAFs (DDB1 CUL4 Associated Factors) (Angers et al., 2006; Bennett et al., 2010; He et al., 2006; Higa et al., 2006; Jin et al., 2006) . A large fraction of these targeting modules is directed toward chromatin-associated proteins. One of the best characterized substrate receptors is the damaged DNA binding protein 2 (DDB2), which binds to UV-induced DNA pyrimidine dimers. The DDB2 receptor is part of the DDB1-DDB2-CUL4-RBX1 E3 ligase complex (CRL4 DDB2 ) (Scrima et al., 2011) . This bi-functional damage detection and ubiquitin ligase complex serves in the repair of UV induced DNA lesions in chromatin.
Exposure of the genomic DNA to ultraviolet light (UV) results in the formation of covalent crosslinks between neighboring pyrimidine nucleotides. These pyrimidine dimers, if left unrepaired, stall transcription by RNA polymerase II (RNAPII). Unrepaired lesions require error-prone translesion polymerases in S phase (Friedberg, 2001) , which potentially introduce oncogenic mutations. Cyclobutane pyrimidine dimers (CPD) and (6-4) pyrimidine-pyrimidone photoproducts (6-4PP) are the two major photo-lesions, accounting for approximately 75% and 25% of genomic UV lesions, respectively (Mitchell et al., 1989 ). Compared to 6-4PP, CPDs cause relatively minor thermodynamic duplex destabilization (Jing et al., 1998) , and are found frequently obscured by organization into nucleosomes (Gale and Smerdon, 1988) . These biophysical and cellular properties render CPDs the most difficult photo-lesion to detect. CPDs are thereby highly mutagenic and major facilitators of skin carcinogenesis (Hoeijmakers, 2009) .
The mammalian global genome repair branch of nucleotide excision repair (NER) surveys the genome for lesions and actively repairs pyrimidine dimers (Aboussekhra et al., 1995) . NER thereby functions as a central pathway in safeguarding metazoan cells against sun-induced skin carcinogenesis. XPC-RAD23-Centrin2 acts as a lesion surveillance complex, recruiting the core NER machinery to damaged sites (Volker et al., 2001) . Assembly of the NER complex results in rapid damage excision and repair synthesis, with repair generally proceeding in a fast and error-free fashion. While XPC is required for global genome NER, it has little or no affinity for CPD lesions, and does not recognize 6-4PP in the context of chromatin (Batty et al., 2000; Sugasawa et al., 2001; Yasuda et al., 2005) . Recently, XPC recruitment to chromatin was shown to be facilitated by the DDB1-DDB2 (UV-DDB) complex (Nishi et al., 2009 ). In the absence of DDB2, XPC remains localized to 6-4PP and to a lesser extent to CPDs, albeit with substantially delayed kinetics (Sugasawa, 2010 ). The precise mechanism of XPC recruitment to sites of UV damage, in the absence of DDB2 is unclear. DDB2 binds to CPD and 6-4PP pyrimidine dimers with the highest reported affinity and specificity of all metazoan damage recognition factors (Payne and Chu, 1994; Wittschieben et al., 2005) . Mutations in DDB2 give rise to XP complementation group E (Tang and Chu, 2002) . In DDB2-deficient XPE cells, CPD repair is largely abolished, while 6-4PP repair is affected to a lesser extent (Hwang et al., 1998; Moser et al., 2005; Tang et al., 2000) . The structural basis of 6-4PP recognition by DDB1-DDB2 is known (Scrima et al., 2008) but it is currently unclear how DDB2 recognizes CPD lesions, which are chemically distinct from the 6-4PP and frequently encapsulated in nucleosomes (Gale and Smerdon, 1988) .
DDB1-DDB2 appears constitutively bound to CUL4 which targets XPC and DDB2 for ubiquitination . In addition, histones H2A, H3 and H4 surrounding the lesion are ubiquitinated in a UV-dependent fashion (GuerreroSantoro et al., 2008; Kapetanaki et al., 2006; Wang et al., 2006) . DDB2 autoubiquitination leads to the loss of DNA damage binding and rapid DDB2 degradation . XPC ubiquitination, in contrast, retains the complex at the site of UV damage without immediate proteasomal degradation. The differential response of XPC and DDB2 upon ubiquitination has been linked to a ubiquitin-dependent damage handover from CRL4 DDB2 to XPC . CRL4 DDB2 is found in complex with the COP9 signalosome (CSN) (Hannss and Dubiel, 2011) . CSN is an 8-subunit isopeptidase complex, which via the proteolytic activity of its CSN5 subunit removes the ubiquitin-like NEDD8 from cullins. NEDD8 is considered as an activator and its removal renders the ligase complex inactive (Furukawa et al., 2000) . Recruitment of CRL4 DDB2 to sites of DNA damage in chromatin appears to correlate with CSN release (Groisman et al., 2003; Takedachi et al., 2010) . The molecular mechanism triggering CRL4 DDB2 activation in response to damage binding is currently unresolved.
While the DDB2 substrate receptor recruits CRL4 DDB2 to DNA damage, other CRL4 substrate receptors are recruited by protein epitopes. Prominent examples include DCAF1, CDT2 and the Cockayne syndrome A (CSA) protein (Lee and Zhou, 2007) . All CRL4 substrate receptors are linked to CUL4 through the DDB1 adaptor. CSA is functionally unrelated to DDB2 and serves in the transcription coupled branch of NER. CRL4 CSA is recruited to sites of CSB and stalled RNA polymerase II, where it facilitates DNA repair and the subsequent transcription restart (Tornaletti, 2009) . Reported CRL4 CSA ubiquitination targets include the Cockayne syndrome B protein (CSB), a SWI/SNF ATPase (Troelstra et al., 1992) . CRL4 DDB2 and CRL4 CSA , as well as other cullin-RING type ligases are inhibited by CSN (Bennett et al., 2010) . It is currently unclear how CSN inhibition is retained at the majority of cellular cullin ligase complexes, while CSN specifically dissociates from those ligases that undergo activation in response to a given stimulus (i.e.: CSN mediated dissociation and activation of CRL4 DDB2 and CRL4 CSA in response to UV). Here, we provide the molecular basis for CRL4 DDB2 recruitment to CPD lesions in chromatin, and characterize how the damage recognition process results in ubiquitin ligase activation, a process mediated by CSN. We present the structure of the DDB1-CSA complex, which in conjunction with biochemical data presented argues in favor of conserved architectural and regulatory principles among CRL4 ligases.
RESULTS

CPD Recognition by DDB2 Involves b-Hairpin Insertion and Lesion Flipping
The DDB2 damage detection module has previously been postulated to undergo conformational changes upon binding of a pyrimidine dimer resulting in CRL4 DDB2 activation in vivo (Takedachi et al., 2010) . We therefore focused on the structure of the DDB1-DDB2 complex bound to CPD-containing duplexes, its physiological substrate. DDB1-DDB2 has the highest reported affinity for CPD lesions among metazoan damage recognition factors. Its absolute affinity, however, was not sufficient to allow successful crystallization in the presence of CPD duplexes. We then engineered DDB1-DDB2 crystal contacts disfavoring crystallization of the DNA-free (apo) state, biasing crystallization toward CPD cocomplexes. This was done by mutating DDB1 contacts that occur only in the apo-DDB1-DDB2 crystal lattice, as DDB1 is not involved in DNA binding ( Figure S1 available online). This approach led to the structures of DDB1-DDB2 bound to four different cis-syn CPD-containing DNA duplexes, observed in different space groups and crystal packing arrangements (Figure 1 ; Figure S1 ). Due to the overall structural similarity among these DNA cocomplex structures, the discussion focuses on the 3.0 Å resolution structure of DDB1-DDB2 bound to a 13-mer duplex having a 5 0 overhang on both strands (CPD#1). Consistent with the DDB1-DDB2 6-4PP complex (Scrima et al., 2008) , the CPD-containing duplex is exclusively held by the DDB2 WD40 propeller. The DNA traverses the central cavity of the WD40 propeller along the axis defined by DDB2 blades 7 and 4, pointing away from DDB1 (Figure 1) . A DDB2 b-hairpin, comprising Phe371, Gln372 and His373 is inserted into the minor groove of the duplex at the site of the CPD. Insertion of this damage-recognition finger (Scrima et al., 2008) proceeds with duplex unwinding of 12.6 ( Figure S1D ), widening of the minor groove to 18 Å (Table S2 ) and extrusion of the CPD into an extra-helical, flipped out conformation. The observed kink angle of the cis-syn CPD DNA in the highest resolution CPD complex is 45 .
The DDB2 Binding Interface Is Specifically Tailored toward CPD Recognition The 6-4PP structure previously revealed few contacts between DDB2 and the extruded 6-4PP (Scrima et al., 2008) . The 6-4PP
has the pyrimidine-pyrimidone rings angled at 90 and can therefore not fully engage the DDB2 damage recognition pocket ( Figures 1C and 1D ). The boat-shaped cis-syn CPD, in contrast, provides a high degree of surface complementarity through Figure S1 and Tables S2 and S3. packing with its hydrophobic carbons (at C5 and C6 positions) against the hydrophobic core of the DDB2 pocket (Figure 1 ). This interaction is stabilized by DDB2 residues Trp239, Ile213, Gly192, and the Ca of Arg214. The four hydrophilic carbonyl groups of the CPD (at the C2/C4 positions), located on the opposing face, are solvent exposed and contact water molecules. The carboxylic group of Asp237 contacts the D +2 pyrimidine nitrogen at N3. The overall arrangement results in a larger contact area of 327 Å 2 for the CPD moiety versus 265 Å 2 for the 6-4PP.
Comparison with existing structures of protein-free CPD duplexes indicated that the DNA conformation seen in the DDB2-CPD complex (Figure 1 ) closely resembles previously observed protein-free cis-syn CPD duplexes ( Figure S1 ). DDB2, through its pyrimidine dimer binding pocket and overall DNA shape complementarity, thereby specifically supports CPD recognition.
The DDB1-DDB2 Complex Does Not Change Its Conformation in Response to Damage Binding The DDB2 6-4PP, THF (Scrima et al., 2008) and CPD structures illustrate that the DNA is intrinsically flexible and can adapt to DDB2 despite differences in the DNA sequence (see Figure S1 ). The plasticity of the DNA is contrasted with the rigidity of DDB2. In all DNA bound and DNA free structures available, DDB2 including its b-hairpin does not change its conformation. Thus, DDB2 serves as a rigid damage recognition unit. As a consequence DDB2 binding to its physiological CPD substrate does not trigger conformational changes that could serve as the signal in ligase activation (see below).
DDB2 Mediated Detection of CPD Lesions in Chromatin
The DDB2 DNA binding interface has previously been proposed to allow readout of lesions embedded in nucleosomes (Scrima et al., 2008) . This is of notable biological importance, as the majority of CPDs appear encapsulated in nucleosomes (Gale and Smerdon, 1988) . The DNA curvature observed when bound to DDB2 matches the nucleosomal curvature (Scrima et al., 2008) which was proposed to facilitate pyrimidine dimer readout through the minor groove. In order to test whether the DDB2 interface is compatible with nucleosomal damage detection, damage-containing nucleosomes were initially prepared by UV irradiation of DNA prior to the assembly of core particles (Extended Experimental Procedures). Electrophoretic mobility shift assays (EMSA) (Extended Experimental Procedures) demonstrated that DDB1-DDB2 is able to specifically recognize irradiated, linker free, mononucleosomes ( Figure 2A ). We subsequently prepared nucleosomes containing a chemically synthesized 6-4PP or CPD lesion (Figures 2B and 2C) . Driven by nucleosome positioning sequence consisting of alternating A/T-and G/C-rich regions, these lesions were located at the sites where the minor groove is oriented away from the surface of the histone octamer (Yasuda et al., 2005) . DDB1-DDB2 recognizes a single 6-4PP embedded in the nucleosome ( Figure 2B , lanes 10-12) and comparable binding can be observed in the presence of the equal amount of 6-4PP-containing naked DNA ( Figure 2B , lanes 13-16). Binding was also detected for the CPD-containing nucleosomes ( Figure 2C ). CPD nucleosome binding was weaker than that of the 6-4PP ( Figures 2D and 2E ), in line with its intrinsically lower helix destabilization (Jing et al., 1998) . Binding of CPD-containing nucleosomes was comparable, however, with DDB2 affinities observed for naked CPD-containing DNA. The DDB2 DNA binding interface in addition to being optimized for CPD recognition, also confers compatibility for detecting CPDs and 6-4PPs in nucleosomes.
Measurements of cellular diffusion rates identified the CRL4 DDB2 complex as the functional macromolecular entity in DDB2 mediated DNA damage recognition (Luijsterburg et al., 2007) . We therefore examined binding of the fully assembled CRL4 DDB2 complex to irradiated nucleosomes ( Figure 2F ). Analogous to our findings with DDB1-DDB2, we observed that the CRL4 DDB2 complex is able to specifically recognize lesions in nucleosomes, suggesting that the presence of CUL4 is compatible with damage recognition in chromatin. In an effort to understand the interplay between damage binding and ligase activation, we subsequently focused on the structure of the CRL4 DDB2 complex bound to damaged DNA duplexes.
Structures of DDB1-DDB2-CUL4A/B-RBX1 Bound to Damage-Containing Duplexes
We first determined the structure of DDB1-DDB2-CUL4A-RBX1 (CRL4A DDB2 ) bound to a 12 bp DNA duplex containing a tetrahydrofuran (THF) lesion, a well characterized DDB2 substrate (Wittschieben et al., 2005) . The structure of this 290 kDa nucleoprotein complex was refined by rigid body refinement to 5.9 Å resolution with an R work of 26.9% (R free of 27%) as outlined in Extended Experimental Procedures. Fragments from previously available high resolution structures of CUL4A (Angers et al., 2006) , DDB1, DDB2, and DNA (Scrima et al., 2008) were positioned using iterative cycles of molecular replacement searches (Extended Experimental Procedures). The location of these individual rigid bodies was validated with anomalous dispersion methods using a selenomethionine (SeMet) labeled CRL4A DDB2 complex. Phases derived from molecular replacement were used for calculation of anomalous difference Fourier electron density maps, which allowed identification of peaks for 50% of the 55 expected Se at 3.0 s (90% at 2.0 s). All peaks were located within 5 Å of their predicted position ( Figure S2D ). Calculation of composite omit maps with CNS (Brunger et al., 1998) further corroborated the correct placement of the different domains of the large complex ( Figure S2C ). Well defined 2 mF obs -DF calc density was observed for CUL4A, DDB1 (BPB, BPC&BPA), DDB2 (helix-loop-helix motif and WD40 propeller) and the 24 nucleotides of the DNA duplex. While density was present for the segment of RBX1 residues 19-39 that integrates into the CUL4A C-terminal b sandwich (Angers et al., 2006) , no density was observed for the remainder. Figure 3 shows the structure of CRL4A DDB2 complex bound to a damage-containing duplex. CRL4A DDB2 assumes an overall U-shaped assembly, with two extended arms of nearly equal length. The thicker arm is contributed by DDB1-DDB2 (extreme dimensions 75 Å x 45 Å ), while the thinner arm comprises CUL4A (75 Å x 23 Å ). The connection between them is made by the N terminus of CUL4A (aa 39-96) in conjunction with the DDB1-BPB domain (Angers et al., 2006) . The DDB1-DDB2 and CUL4A extended arms are angled at about 50 . The overall complex assumes an approximately square arrangement (160 Å x 140 Å ). The largely helical CUL4A fold is attached exclusively to the BPB WD40 propeller of DDB1 (Figure 3 ). The observed distances between the CUL4A arm and the remainder of the DDB1 (BPC+BPA) propellers are generally more than 15-20 Å . The distance between CUL4A and the DNA duplex is around 50 Å . This arrangement excludes specific interactions between CUL4A and the DNA, or CUL4A and the BPA and BPC propellers of DDB1 (Figure 3 ).
The CUL4A and CUL4B Ligases Are Structurally Indistinguishable Since human cells possess two CUL4 isoforms, CUL4A and CUL4B (Jackson and Xiong, 2009 ) with DDB1-DDB2 reported to exist in complex with both of them (Groisman et al., 2003; Wang et al., 2006) , we determined the crystal structure of CUL4B-RBX1 bound to DDB1-DDB2 in the presence of a second 12 bp THF containing duplex DNA (7.4 Å resolution). While the cullin fold of CUL4B (aa 192-913) has high sequence identity to CUL4A (84% over 722 residues), the CUL4B N terminus is unique to CUL4B. The CUL4B aa 1-191 N terminus was predicted to be mostly unstructured and was removed prior to coexpression of the CRL4 DDB2 complex.
In the absence of known CUL4B structures, we first determined the structure of CUL4B (in complex with CAND1) at 3.8 Å resolution (Extended Experimental Procedures). Analysis of CUL4A and CUL4B folds revealed superimposable structures (rmsd of 1.54 Å over 677 residues) rendering the two homologs structurally indistinguishable (see Figure 4C and Figure S3 for the mapping of CUL4B mutations resulting in X-linked mental retardation).
The CUL4 E3 Ligase Freely Rotates Around a Rotation Axis Defined by DDB1 and the Damage The structure of the DDB1-DDB2-CUL4B-RBX1 (CRL4B  DDB2 ) complex was solved following a similar strategy, as outlined for CRL4A DDB2 (Extended Experimental Procedures). The overall architecture of the two CRL4B DDB2 complexes, observed in the asymmetric unit was comparable with CRL4A DDB2 (Figure 4 ).
Clear density for RBX1, again was only visible for aa 19-39 in both molecules of CRL4B
DDB2
.
Comparison of the CRL4A DDB2 with the two CRL4B DDB2 molecules revealed the DDB1-BPB domain in three different rotational states. As the BPB domain is the anchor point of the CUL4 ligase, its mobility directly translates into the mobility of the entire ligase arm. Within the three molecules observed in our study ( Figures 4A and 4B ), CUL4 rotates around 60 along an axis defined by the damage and DDB1 (BPB propeller) (Figure 4 ). Minimal distances observed between CUL4B and DNA, and between CUL4B and DDB1 (BPC), for the two CUL4B molecules were between 25-35 Å and 5-27 Å , respectively. The cullin fold with its kink of 80 between cullin repeats 1 and 2 is shaped to allow rotation over BPC blades 2 and 3 toward the DDB1 C terminus without steric clashes with DDB1 (Figure 4) .
The DDB1 BPB Domain Mobility Structurally Insulates the CUL4 Ligase from the DDB2 Module Examination of the 11 available medium/high resolution DDB1 molecules obtained in crystallographic studies (Angers et al., 2006; Li et al., 2006; Li et al., 2010; Scrima et al., 2008 ) suggest a total BPB domain rotation range of at least 150 ( Figure 4D ). Analysis of the expected energetics of rotation, as calculated by differences in solvation energy for the individual DDB1 (BPB) versus DDB1 (BPC-BPA) interfaces (Krissinel and Henrick, 2007) predicts that the observed rotations are iso-energetic (Figure 4E) . As a consequence, CRL4
DDB2 is expected to rotate up to 150 establishing a ubiquitination zone restricted to 60-80 Å . Upon modification with the small ubiquitin like modifier NEDD8 and resultant release of RBX1, the ubiquitination zone increases to 30-110 Å (Duda et al., 2008) (Figure 4D ).
The overall modular architecture of CRL4 DDB2 implies that CUL4 cannot be directly activated through conformational changes induced by DDB2 damage binding. The mobility of the ligase arm further insulates CUL4 from DDB2. Activation of the ligase in response to DNA damage therefore requires additional factors. We next focused on known regulators and their role in CRL4 DDB2 regulation.
The DDB2-N Terminus Is Autoubiquitinated and Regulates DDB2 Levels after UV Irradiation The CRL4 DDB2 complex, in vivo, undergoes DDB2 autoubiquitination and degradation following UV irradiation. In contrast, the recombinant CRL4 DDB2 complex undergoes DDB2 autoubiquitination irrespective of the presence and absence of DNA damage. The DDB2 subunit has previously been shown to undergo polyubiquitination at multiple sites . Using mass spectrometry, in conjunction with a ubiquitin variant lacking lysine residues required for polyubiquitination, we identified the human DDB2 Lys residues 5, 11, 35, 40 and 151 as the main targets for CRL4 DDB2 autoubiquitination in vitro ( Figures   S4A-S4D ). The majority of these sites (Lys5, 11, 35 and 40) are located within the unstructured DDB2 N terminus. When determining the human DDB1-DDB2 complex structure DDB2 aa 1-59 were absent from the electron density maps, and were removed for subsequent structural studies. In vitro, deletion of the DDB2 N terminus, aa 1-40 (DDB2 DN ), ablated the majority of ubiquitin acceptor sites ( Figure 5A ). On the basis of randompolymer-theory (Creighton, 1992) the very N terminus of DDB2 is estimated to have a root-mean-square distance of about 90 Å from the beginning of the DDB2 structure (aa 1-66). The DDB2 N terminus is thereby located on the edge of the active ubiquitination zone of the ligase. Next, we assessed the effect of these lysine residues in cells, in response to UV damage. A normal human fibroblast cell line, WI38 VA13, was used to stably express HA-tagged wild-type DDB2 or a construct in which 7 N-terminal lysines (at positions 4, 5, 11, 22, 35, 36, and 40) were mutated to arginines (DDB2 7KR ). DDB2 7KR remained associated with DDB1 and CUL4 in a manner identical to that seen for wild-type DDB2 ( Figure 5B ). After blocking translation by cycloheximide treatment and UV irradiation, DDB2 7KR showed remarkable stability compared to the wildtype DDB2; cellular wild-type DDB2 levels mostly disappeared 1 hr after UV, whereas DDB2 7KR levels remained unchanged for 5 hr ( Figure 5C ). Differences in total levels of wild-type DDB2 and DDB2 7KR are visible as early as 30min post UV, at a time when CSN has previously been shown to dissociate from the complex (Groisman et al., 2003 (C) The cell line stably expressing HA-DDB2-FL or HA-DDB2-7KR was exposed to UV irradiation 2 hr after treatment with 1 mM cycloheximide (CHX) in the presence or absence of 5 mM MG132. Cells were further incubated for various times in the presence of CHX (±MG132) and whole cell extracts were subjected to immunoblotting using indicated antibodies. (D) In vitro ubiquitination assays were performed with wild-type CRL4A DDB2 complex and analyzed by DDB2 immunoblot. Wild-type CSN complex (lane 4)
or a complex containing a CSN5 active site mutant (lane 5) significantly inhibited the autoubiquitination of DDB2. This inhibition was relieved by the addition of UV-irradiated DNA to the reaction (lanes 5 and 7). (E) Small oligonucleotides containing an THF abasic site mimic (lane 3), CPD lesion (lane 4) or 6-4PP lesion (lane 5) were sufficient to relieve the inhibition, whereas an undamaged oligonucleotide of similar length did not affect the inhibition (lane 6). Ubiquitin-aldehyde had no effect on the reaction (lane 1 and 2). (F) In vitro ubiquitination assays were performed with CRL4A DDB2 complex harboring the K244E DDB2 patient mutation. In contrast to wt DDB2, the inhibition by CSN ASM was not relieved upon damaged DNA addition (lane 4). See also Figures S4 and S5 and Table S5. were not degraded in response to UV in the presence of MG132, an inhibitor of the proteasome (Rapi c-Otrin et al., 2002) (Figure 5C ). The lysine residues at the DDB2 N terminus (aa 5-40), which are targeted by CRL4 DDB2 for autoubiquitination in vitro, hence regulate the overall cellular concentration of DDB2 in response to UV.
The COP9 Signalosome Mediates Activation between DDB2 and the Ubiquitin Ligase DDB2 is autoubiquitinated by CRL4 DDB2 in cis irrespective of the presence or absence of DNA damage in vitro. In vivo, however, DDB2 ubiquitination and degradation proceeds in a DNA damage specific fashion. CSN has been implicated in CUL4 inhibition through deneddylation, and is known to dynamically associate with CRL4 DDB2 complexes (Groisman et al., 2003) . Dissociation of the CSN from CRL4 DDB2 had previously been observed in the presence of nucleosomes (Takedachi et al., 2010) . We first examined the effect of CSN on CRL4 DDB2 autoubiquitination. DDB2, within the CRL4 DDB2 complex, was readily ubiquitinated in the presence of an E1 (UBA1) and E2 (UbcH5A), as previously observed . DDB2 autoubiquitination, however, was severely inhibited in the presence of CSN ( Figure 5D , lanes 4 and 6). The inhibitory effect of CSN was observed in the presence of wild-type CSN5, or using a CSN5 catalytic mutant deficient in deneddylation (CSN ASM ). We then carried out ubiquitination reactions in the presence of irradiated DNA plasmids. Under these conditions CSN, or CSN ASM , no longer protected DDB2 from undergoing autoubiquitination ( Figure 5D , lanes 5 and 7). We then examined the DNA specificity of activation. Short duplexes between 15 and 24bp in length containing either THF, 6-4PP or CPD ( Figure 5E ) were sufficient to overcome CSN inhibition and triggered DDB2 autoubiquitination. Duplexes containing undamaged DNA, on the other hand, did not relieve protection ( Figure 5E , lane 6). Analogously, a DDB2 (K244E) mutant defective in damage DNA binding (Wittschieben et al., 2005) was unable to relieve CSN inhibition ( Figure 5F ). EMSA and equilibrium sizeexclusion chromatography indicated that CRL4 DDB2 dissociated from the CSN-CRL4 DDB2 in the presence of small damage-containing DNA duplexes ( Figure S5 ). We thereby conclude that substrate binding to the DDB2 subunit of CRL4 DDB2 triggers CSN release, relieves inhibition and results in an active ligase complex. The DDB2 N terminus subsequently becomes subjected to CRL4 DDB2 autoubiquitination, which triggers cellular DDB2 degradation in response to UV irradiation. Previous studies reported a deubiquitination (DUB) enzyme, UBP12, associated with CSN preparation immunopurified from human cells (Zhou et al., 2003) . Our recombinant CSN, overexpressed and purified to homogeneity from insect cells (Enchev et al., 2010) (Figure S4 ) did not show any discernable deubiquitination activity, in the presence or absence of damaged DNA ( Figure S4 ). In addition, while UBP12 DUB activity was previously shown to be inhibited by ubiquitin-aldehyde (Zhou et al., 2003) , we observed no such effect on DNA mediated CRL4 DDB2 activation in the presence of 3.9 mM ubiquitin-aldehyde ( Figure 5E , lanes 1 and 2), a concentration that was sufficient to inhibit a control DUB added to the reaction ( Figure S5E ). The CSN inhibitory properties observed in vitro are therefore intrinsic to the complex and not due to CSN5 mediated deneddylation, or CSN associated DUB activity. In a minimal, recombinant system we have fully reconstituted DNA damage-dependent activation of CRL4 DDB2 mediated by CSN (see Figure S5 for mapping of CSN subunits required for protection/release). While the CRL4 DDB2 complex, as depicted in Figures 3 and 4 , is active in the presence of E1 and E2 conjugating enzymes, its activity is inhibited by CSN. The presence of UV damaged DNA serves to relieve CSN inhibition providing a mechanism for DNA dependent activation of the CRL4 DDB2 ligase.
The CSA DDB1 Complex Reveals a Common Architecture of the DDB1-DCAF Family DDB2 is a member of the large family of DCAFs, functioning as a DNA damage specific receptor recruiting CRL4 DDB2 to pyrimidine dimer sites. Additional DCAFs have been described, the majority of which serve as substrate receptors to CRL4 ubiquitin ligases. These receptors likely do not bind DNA, but rather recognize proteins. In the CRL4 DDB2 structures, DDB2 emerges as modular unit insulated from the CUL4 ligase. The absence of specific interactions between DDB2 and CUL4 would principally allow exchange of DDB2 for other WD40 containing substrate adaptors. We thus focused on the DDB1-CSA-CUL4-RBX1 (CRL4 CSA ) ligase, seemingly unrelated to DDB2 besides the WD40 repeat in its protein sequence, which functions in the transcription-coupled repair (TCR) branch of NER (Fousteri and Mullenders, 2008) . Cockayne syndrome (CS) is a rare congenital disease exhibiting defects in the TCR branch of NER. The stalling of RNAPII observed in the presence of damaged nucleotides tightens the interaction between the RNAPII and the Cockayne syndrome B (CSB) SWI/SNF ATPase. The complex of RNAPII and CSB in turn is a prerequisite for the arrival of the Cockayne syndrome A protein complex (CRL4 CSA ) (Fousteri et al., 2006) . Both CSA and CSB are required for successful repair and transcription restart. CRL4 CSA has been implicated in the ubiquitination and subsequent degradation of CSB in a UV-dependent fashion (Groisman et al., 2006) . We have determined the structure of the human DDB1-CSA complex at 3.3 Å resolution (Figure 6 ). The structure was solved by molecular replacement as outlined in Extended Experimental Procedures. CSA comprises a seven-bladed WD40 propeller (aa 30-365) that attaches to DDB1 through a helix-loop-helix motif (aa 1-29). The CSA helix-loop-helix motif (HLH-box) and the WD40 propeller were well ordered, whereas no interpretable electron density was found for the C terminus of CSA (aa 364 to 396) and the C-terminal affinity tag. Irrespective of the limited (20%) sequence identity between DDB2 and CSA, the DDB1-CSA and DDB1-DDB2 complexes show high overall structural similarity (backbone rmsd of 3.4 Å for 355 CSA/ DDB2 residues).
The location of CSA patient mutations are indicated in Figure 6B . We note that CSA mutations resulting in milder forms of CS type III (and UV sensitive syndrome UV S S) are point mutations expected to cause only limited structural damage. Mutations giving rise to the more severe forms, CS type I and II are point mutations, deletions and premature chain (C) HMM based sequence logo and corresponding secondary structure of the helix-loop-helix box (see Figure S6A for full alignment).
(D-G) Superposition using DDB1-BPA/BPC results in a similar orientation of CSA (blue) and DDB2 (green) showing the common architecture of the complexes. Close-up view of the helix-loop-helix motif in hsCSA (E), drDDB2 (F) and hsDDB2 (G), respectively. Residues belonging to the conserved motif are indicated. See also Figures S6 and S7 and Table S6. termination mutations expected to severely compromise the CSA structure (see Table S6 for detailed analysis of CSA patient mutations and discussion of structure and phenotype correlations).
The CSA-DDB1 Interaction Is Mediated through the HLH-BOX DDB1 comprises three WD40 domains (BPA, BPB and BPC) and a C-terminal a-helical domain (CTD). We found that CSA binds to DDB1 with an N-terminal HLH-box segment formed by aa 1-29 ( Figures 6A and 6D ). The HLH-box localizes to a cleft between the DDB1 propellers BPA and BPC. The two parallel HLH-box helices, a1 and a2, pack against each other. The HLH-box interaction surface with DDB1 encompasses the outer surface of a1 and the N-terminal tip of a2 (aa [16] [17] [18] [19] [20] . The majority of CSA a1 interactions with DDB1 are hydrophobic (CSA Met1, Leu5), or contact DDB1 through H-bonds (CSA Ser6, Arg8, Gln9). While a1 is buried deeply in the BPC DDB1 propeller, a2 is further detached from DDB1 pointing toward the DDB1 (BPA) propeller. CSA a2, contacts DDB1 largely through H-bonds and long-range salt bridges comprising CSA a2 residues Arg17 and Arg20, respectively.
Analysis of Helix-Loop-Helix Motifs Identified in Other WD40-Containing DCAFs
The unexpected structural similarity between DDB2 and CSA prompted us to reinvestigate whether the majority of WD40 containing DCAFs bind DDB1 in a similar fashion. In proteomic studies approximately 50 WD40-containing DCAFs proteins were identified as putative substrate receptors (Angers et al., 2006; Bennett et al., 2010; He et al., 2006; Higa et al., 2006; Jin et al., 2006) . Out of the 18 WD40-containing DCAFs, identified in at least two proteomic studies, 13 contained an HLH-box ( Figure S6A ). In addition to the conserved a1 helix (Fukumoto et al., 2008; Li et al., 2010) (Figures 6D-6G ), we now also detect conservation for helix a2. The beginning of a2 (residues +1 to +3) is composed of small and hydrophilic side chains, followed by large hydrophobic residues (Phe, Leu and Tyr) at the +4 position, which pack against a1 ( Figure 6C) . A large, often polar, residue is found in the +6 position interacting with DDB1 (BPA). The length of the loop between a1 and a2 appears nonconserved and varies between 2 and 7 residues. Based on these sequence signatures, we identify DDB1-(WD40) DCAF family members CDT2, DCAF1, WDR21, WDR23, WDR40, WDR22, WDR32, and PHIP among others ( Figure S6 ) as having a HLH-box predicted to bind DDB1 in a manner similar to DDB2 and CSA. The resultant CRL4 DCAF(WD40) complexes are expected to strongly resemble CRL4 DDB2 sharing principle properties such as ligase mobility (see Figure S6C for a model of CRL4 CSA ). We then tested the functional interplay between CRL4 CSA and CSN in vitro. We observed that CSA is also autoubiquitinated in vitro ( Figure 7A , lane 2) and that CSA autoubiquitination is in turn inhibited by the addition of CSN (or CSN ASM ) ( Figure 7A , lane 3 and 5). Providing the CRL4 CSA substrate CSB relieved CSN inhibition, and led to ubiquitination of CSB and CSA (Figure 7A, lanes 4, 6, and 7, and Figure 7B) . In a fully recombinant in vitro system, damage DNA binding to CRL4
DDB2
, as well as CSB binding to CRL4 CSA , displaces CSN resulting in activation of the CRL4 ligase complex.
The overall functional and regulatory constraints following from the CRL4 DDB2 (and CRL4 CSA ) architectures thus likely extend to other members of the CRL4 DCAF family.
DISCUSSION
The Molecular Basis of Targeting, Recruitment, and Activation of the CRL4 DDB2 Ligase in Chromatin
On the basis of our findings, we propose the following working model for CRL4 DDB2 recruitment and activation in response to UV damage ( Figure 7C ): In the absence of DNA damage, nuclear CRL4 DDB2 is complexed to CSN in a nonchromatin-bound form (Groisman et al., 2003) . Following UV damage, CRL4 DDB2 -CSN is recruited to DNA by its ability to interrogate nucleosomes for the presence of 6-4PP and CPD lesions (Figure 2 ). CRL4 DDB2 is structurally optimized for recognition of CPDs, which due to their small intrinsic helix destabilization frequently escape detection by other damage surveillance factors (Figure 1) . XPC-RAD23, alone, has no significant affinity for CPD and is unable to detect 6-4PP lesions in chromatin (Yasuda et al., 2005 ). Yet XPC is essential for efficient NER repair. The ability of CRL4 DDB2 to recognize 6-4PPs, and particularly CPDs, embedded in nucleosomes provides a pathway to recruit XPC to lesions in chromatin and activate the ligase thus facilitating NER (Sugasawa, 2006) . We find that DNA damage binding to Figure 5F ).
The Architecture of the CRL4 DCAF Family
The CRL4 DDB2 ligase is perceived to be a special case, as it recognizes a nonprotein substrate. The ligand, in this case DNA, is atypically not the target for ubiquitination, but rather proteins in its proximity are the entities ubiquitinated. In order to examine how other CRL4 DCAF complexes, structurally and functionally, relate to CRL4 DDB2 , we determined the structure of the DDB1-CSA complex. The DDB1-CSA complex, which was shown to bind a protein epitope rather than damaged DNA (Groisman et al., 2006 ) revealed a surprising overall architectural similarity to the DDB1-DDB2 complex. We find that CSN mediated inhibition of CRL4 CSA is released through addition of CSB, similar to what has been observed for CRL4 DDB2 . In vivo, the disappearance of CSN from the CRL4 CSA complex (ca. 4 hr post-UV) coincides with ubiquitination and disappearance of CSB (Groisman et al., 2006 (Duan and Smerdon, 2010) . Binding to chromatin/nucleosome results in steric displacement of CSN (involving CSN subunits 1,2,3,4, and 6) and ligase activation. This in turn allows for ubiquitination of diverse substrates within the zone of ubiquitination including histones, XPC and DDB2.
displaces CSN (Figures 7A and 7B) . Indeed, we observe in CRL4
DDB2
-CSN negative stained EM single particle reconstructions that the DDB2 subunit is held in close proximity to CSN (data not shown). Other structurally related CRL4 DCAF complexes are thus expected to bind CSN in a similar fashion. This strongly suggests that CSN release and subsequent activation of CRL4 DCAF complexes are simply triggered by substrate binding to the DCAF within the CRL4 DCAF -CSN complex.
Protection of substrate receptors by CSN has previously been described for the CRL1 and CRL3 families in vivo (Bornstein et al., 2006; Schmidt et al., 2009; Zhou et al., 2003) and likely extends to the CRL4 family (Bennett et al., 2010) . The protective effect of CSN on DDB2 autoubiquitination observed in this study is independent of deubiquitinating enzymes, and does not require CSN5 mediated deneddylation (see Figure S5 for CSN subunits required for inhibition). Similar properties have been observed for the CSN-CRL4
CSA interplay, although the cellular role of CSA autoubiquitination is unclear at present. In vivo, (1) the intrinsic CSN deneddylase activity, (2) CSN-associated deubiquitinases, and (3) the nonenzymatic CSN inhibition observed are all expected to act in concert inhibiting CRL4 in the absence of an activating cue. Further work is needed to define the relative contribution of these three strategies (1-3) to CSN mediated inhibition in vivo. However, all three levels of inhibition are simultaneously relieved once DDB2 (CSA) contacts DNA damage (CSB), as the direct contact between receptor and substrate results in CSN dissociation and loss of receptor protection. In light of the conserved architecture of the majority of CRL4 DCAF(WD40) complexes this provides a general mechanism for regulating the CRL4 CSN interplay.
EXPERIMENTAL PROCEDURES Protein Expression and Purification
All proteins used for structure determination were cloned into pFastBac Dual vectors (Invitrogen) and expressed and purified from High Five cells (Invitrogen) as outlined in Scrima et al., 2008 (see also Extended Experimental Procedures) . Purified recombinant CSB protein was provided as a kind gift from Regina Groisman. Enzymes for neddylation such as NAE1/UBA3 and UbcH12, as well as NEDD8, were purified as N-terminal His 6 fusion proteins from Escherichia coli (Duda et al., 2008) . hsUBA1, hsUbcH5A, hsUbcH5B, hsUbiquitin and hsUbiquitin-K0 were purchased from Boston Biochem.
Oligonucleotides Used in This Study
Single stranded DNA oligonucleotides and oligonucleotides containing tetrahydrofuran (THF) lesion were purchased from Sigma Aldrich. Oligonucleotides containing the cis-syn CPD were synthesized using phosphor-amidite building blocks (Glenn Research, USA). Sequences of oligonucleotides used are provided in the Tables S4 and S5 .
Crystallization and Structure Solution
Crystallization conditions as well as data collection and refinement statistics are given in Table S1 .
Cellular Assays
HA-tagged DDB2 (wild-type or mutant) was stably overexpressed in a normal human fibroblast cell line, WI38 VA13, by using the pIREShyg vector. The transformed cells were exposed to UVC (10 J/m 2 ) and incubated for various times. Whole-cell extracts were prepared and analyzed by immunoblotting.
In Vitro Ubiquitination Assays
Assays for autoubiquitination were carried out as described in Sugasawa, 2006 . Antibodies used include a-hsDDB2 (AF3297, R&D Biosystems), a-XPC , a-CSA (GTX100145, GeneTex), a-CSB (SC10458, Santa Cruz) and horseradish peroxidase (HRP)-conjugated secondary antibodies against Goat IgG (R&D Biosystems) and rabbit IgG (GeneTex).
ACCESSION NUMBERS
The following structural coordinates have been reported: CPD#1(pdb:4A08), CPD#2(pdb:4A09), CPD#3(pdb:4A0A), CPD#4(pdb: 4A0B), CAND1-CUL4B (pdb:4A0C), CRL4A DDB2 -DNA(pdb:4A0K), CRL4B DDB2 -DNA(pdb:4A0L), and DDB1-CSA(pdb:4A11).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, six tables, and seven figures and can be found with this article online at doi:10.1016/j.cell.2011.10.035.
